Financial Performance - In 2024, the company's revenue decreased by 5.97% to ¥927,932,105.81 compared to ¥986,897,245.84 in 2023[22] - The net profit attributable to shareholders dropped by 64.56% to ¥55,987,316.48 from ¥157,989,001.88 in the previous year[22] - The net profit after deducting non-recurring gains and losses fell by 80.56% to ¥29,515,889.67, down from ¥151,859,536.11 in 2023[22] - The basic earnings per share decreased by 64.56% to ¥0.1331 from ¥0.3756 in the previous year[22] - The total assets at the end of 2024 were ¥2,388,723,256.19, a decrease of 3.79% from ¥2,482,942,697.11 in 2023[22] - The company's total revenue for Q1 2024 was approximately ¥239.94 million, Q2 was ¥254.71 million, Q3 was ¥201.35 million, and Q4 was ¥231.94 million[24] - The net profit attributable to shareholders for Q1 2024 was ¥25.70 million, Q2 was ¥28.31 million, Q3 showed a loss of ¥1.76 million, and Q4 was ¥3.74 million[24] - The net profit after deducting non-recurring gains and losses for Q1 2024 was ¥21.68 million, Q2 was ¥20.41 million, Q3 was a loss of ¥6.23 million, and Q4 was a loss of ¥6.34 million[25] - The net cash flow from operating activities for Q1 2024 was ¥13.73 million, Q2 was a negative ¥1.26 million, Q3 was ¥33.62 million, and Q4 was ¥5.64 million[25] Research and Development - The company plans to enhance R&D innovation and improve operational quality to adapt to the changing international environment[4] - The company has increased its R&D investment and improved production processes, focusing on green circular economy practices[35] - The R&D team consists of 195 personnel, including 10 with doctoral degrees, focusing on high-end chemical products and high-performance polymer materials[42] - The company's R&D investment amounted to ¥53,803,033.87 in 2024, representing 5.80% of its operating revenue, an increase from 5.22% in 2023[75] - The total number of R&D personnel increased to 195 in 2024, a rise of 1.56% compared to 192 in 2023[75] Market and Product Development - The company is a leading producer of chlorosulfonic acid and aramid polymer monomers, with significant market influence and established partnerships with major manufacturers in Japan and South Korea[34] - The company is focused on developing new lithium-ion battery electrolyte products and improving production processes, which are expected to positively impact future operations[72] - The company is actively expanding its product lines, including a 1,000 tons/year chlorinated diphenyl sulfone technical transformation project, which is currently in operation[50] - The company is focusing on expanding its product range through the development of new chemical products, including high-purity chlorinated compounds and sulfonated polyether ketones[74] - The company aims to enhance its market competitiveness by optimizing production processes and reducing costs through advanced research and development initiatives[74] Environmental and Safety Management - The company emphasizes safety and environmental management, adhering to various environmental laws and implementing measures to reduce emissions and enhance waste treatment[43] - The company has established an environmental management department and implemented regulations to ensure compliance with environmental laws[107] - The company has implemented a comprehensive safety risk management system, utilizing HAZOP analysis to identify and assess safety risks across processes and facilities[186] - The company has committed to environmental protection by adhering to national and local environmental laws, ensuring that all pollutants were within discharge standards during the reporting period[182] - The company has established an emergency response plan for environmental incidents, enhancing its ability to manage potential pollution risks[173] Corporate Governance - The company has conducted multiple shareholder meetings to ensure compliance with legal requirements and protect shareholder rights[114] - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance standards[116] - The company maintains a high level of information disclosure and transparency, utilizing platforms such as China Securities Journal and CNINFO for communication with investors[119] - The company has established an internal control system to regulate management and mitigate risks, ensuring compliance with relevant laws and regulations[118] - The company has not reported any instances of the controlling shareholder interfering with its decision-making or operations, ensuring independence in business and financial matters[122] Financial Management - The company achieved a total cash inflow from operating activities of ¥680,413,405.55, an increase of 11.47% from ¥610,382,741.55 in 2023[77] - The net cash flow from investment activities decreased by 3,161.94% year-on-year, attributed to increased management of financial assets based on operational funding needs[78] - The net cash flow from financing activities fell by 116.27% year-on-year, mainly due to the previous year's issuance of convertible bonds that raised ¥639,730,000[78] - The company reported a credit impairment loss of CNY -14,282,523.01, which is -23.60% of total profit, mainly due to the provision for bad debts on other receivables by subsidiaries[79] - The company has received government subsidies and deferred income amortization contributing CNY 14,795,057.09, which is 24.45% of total profit[79] Production and Operational Efficiency - The company employs a production model of "sales-driven production + strategic inventory," ensuring timely and quality product delivery while adhering to safety and environmental standards[38] - The company has implemented automated control systems in production to ensure stability and safety, alongside energy-saving and quality-enhancing measures[40] - The company has established long-term stable relationships with major suppliers for essential raw materials, ensuring a reliable supply chain[38] - The company has a strong technical accumulation and process advantages, with core technologies in the production, purification, and testing of chlorosulfonic acid and acyl chloride products, achieving a product purity of over 99%[51] - The company has implemented digital and automated upgrades to enhance production efficiency, resulting in a noticeable decrease in steam consumption[176] Strategic Planning - The company will focus on sustainable development and market share expansion as part of its long-term strategy[4] - The strategic development plan includes extending from fine chemicals to high-performance polymer materials and new energy sectors, enhancing overall competitiveness[56] - The company is actively pursuing potential mergers and acquisitions to enhance its product offerings and market reach[129] - The company plans to reduce its chlorosulfonic acid production capacity by 50,000 tons within three years, ensuring that the revenue from chlorosulfonic acid products accounts for less than 15% of its main business income[193] - The company has committed to a long-term strategy of sustainable and efficient development, focusing on green and circular economy practices[103]

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-004 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 第三届董事会第二十九次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、会议召开及议案审议情况 - 1 - （四）会议以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《2025 年度预算报告》 山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第二十九 次会议通知于 2025 年 3 月 3 日以电子邮件的形式发出，2025 年 3 月 13 日于公 司会议室通过"现场+通讯"的方式召开，公司 9 名董事都参加了本次会议，会 议的通知及召开符合《公司法》及《公司章程》的规定，合法有效。本次会议由 董事长王加荣先生主持，经与会各位董事认真讨论研究，审议并通过了以下议案： （一）会议以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《2024 年度总经理工作报告》 （二）会议以 9 票赞成、0 票反对、0 票弃权的表决 ...

山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第二十八 次会议通知于 2025 年 2 月 18 日以电子邮件的形式发出，2025 年 2 月 21 日通过 通讯表决的方式召开，公司 9 名董事都参加了本次会议，会议的通知及召开符合 《公司法》及《公司章程》的规定，合法有效。本次会议由公司董事长王加荣先 生主持，经与会各位董事认真讨论研究，以 9 票赞成、0 票反对、0 票弃权的表 决结果审议通过了《关于制定<市值管理制度>的议案》： 为进一步加强公司市值管理工作，维护公司及广大投资者合法权益，公司积 极响应中国证监会《上市公司监管指引第 10 号—市值管理》关于鼓励上市公司 建立市值管理制度的号召，根据《中华人民共和国公司法》《中华人民共和国证 券法》等法律、法规及《深圳证券交易所股票上市规则》及其他相关规定，现决 定制定公司《市值管理制度》。 二、备查文件 第三届董事会第二十八次会议决议。 特此公告。 | 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-003 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 ...

Financial Performance Forecast - The company expects a net profit attributable to shareholders of between 47 million and 61 million RMB for 2024, representing a decline of 70.25% to 61.39% compared to the previous year's profit of 157.99 million RMB[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 24 million and 31 million RMB, a decrease of 84.20% to 79.59% from last year's profit of 151.86 million RMB[4] Reasons for Decline - The decline in performance is attributed to decreased demand in the downstream market and intensified industry competition, leading to a drop in both volume and price of main products[6] - The company incurred interest expenses exceeding 30 million RMB from convertible bond fundraising, contributing to the overall decline in revenue and profit[6] Financial Reporting - The performance forecast is based on preliminary calculations by the company's finance department and has not been audited by an accounting firm[7]

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-001 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 关于2024年第四季度可转债转股情况的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 根据《深圳证券交易所股票上市规则》和《深圳证券交易所可转换公司债券 业务实施细则》的有关规定，山东凯盛新材料股份有限公司（以下简称"公司"） 现将 2024 年第四季度可转换公司债券（以下简称"可转债"）转股及公司股份变 动的情况公告如下： 一、可转换公司债券上市发行情况 （一）可转换公司债券发行情况 根据中国证券监督管理委员会《关于同意山东凯盛新材料股份有限公司向不 特定对象发行可转换公司债券注册的批复》（证监许可〔2023〕1893 号），山东凯 盛新材料股份有限公司（以下简称"公司"）获准向不特定对象发行可转换公司 债券 650.00 万 张 ， 每 张 面 值 为 人 民 币 100.00 元 ， 募 集 资 金 总 额 为 650,000,00 ...

西南证券股份有限公司关于山东凯盛新材料股份有限公司 经中国证券监督管理委员会 2021 年 8 月 10 日下发的《关于同意山东凯盛新 材料股份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕2626 号）， 同意公司首次公开发行人民币普通股（A 股）股票 6,000 万股，每股面值 1 元， 每股发行价格为人民币 5.17 元，募集资金总额人民币 31,020.00 万元，扣除与发 行有关的费用（不含增值税）人民币 2,830.85 万元，公司实际募集资金净额为人 民币 28,189.15 万元。 公司募集资金已于 2021 年 9 月 22 日到账，四川华信（集团）会计师事务所 （特殊普通合伙）对公司首次公开发行股票的资金到位情况进行了审验，并于 2021 年 9 月 22 日出具了川华信验（2021）第 0076 号《验资报告》。 公司已对募集资金进行了专户存储，并与保荐机构、存放募集资金的银行签 署了募集资金三方监管协议。 经公司第三届董事会第七次会议、第三届监事会第七次会议和 2022 年第二 次临时股东大会审议，公司决定对"2000 吨/年聚醚酮酮树脂及成型应用项目"中 首期项目进行结项 ...

（一）以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《关于募投 项目延期的议案》。 本议案已经公司第三届董事会第一次独立董事专门会议审议通过，公司独立 董事一致同意本次募投项目延期的事项。 详见公司于同日在巨潮资讯网（www.cninfo.com.cn）披露的《关于募投项目 延期的公告》（公告编号：2024-051）。 | 证券代码：301069 | 证券简称：凯盛新材 公告编号：2024-049 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 第三届董事会第二十七次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、会议召开及议案审议情况 山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第二十七 次会议通知于 2024 年 12 月 23 日以电子邮件的形式发出，2024 年 12 月 27 日通 过通讯表决的方式召开，公司 9 名董事都参加了本次会议，会议的通知及召开符 合《公司法》及《公司章程》的规定，合法有效。本次会议由董事长王加荣先生 ...

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2024-051 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 （一）募集资金基本情况 经中国证券监督管理委员会 2021 年 8 月 10 日下发的《关于同意山东凯盛 新材料股份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕2626 号），同意公司首次公开发行人民币普通股（A 股）股票 6,000 万股，每股面值 1 元，每股发行价格为人民币 5.17 元，募集资金总额人民币 31,020.00 万元， 扣除与发行有关的费用（不含增值税）人民币 2,830.85 万元，公司实际募集资 金净额为人民币 28,189.15 万元。 公司募集资金已于 2021 年 9 月 22 日到账，四川华信（集团）会计师事务 所（特殊普通合伙）对公司首次公开发行股票的资金到位情况进行了审验，并 于 2021 年 9 月 22 日出具了川华信验（2021）第 0076 号《验资报告》。公司已 对募集资金进行了专户存储，并与保荐机构、存放募集资金的银行签署了《募 集资金三方监管协议》。 ...

关于使用暂时闲置募集资金进行现金管理的公告 | 证券代码：301069 | 证券简称：凯盛新材 公告编号：2024-052 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 山东凯盛新材料股份有限公司（以下简称"公司"）于 2024 年 12 月 27 日召 开第三届董事第二十七次会议和第三届监事会第二十五次会议，分别审议通过了 《关于使用暂时闲置募集资金进行现金管理的议案》，同意公司在确保不影响募 集资金投资项目建设、不影响正常生产经营及确保资金安全的情况下，使用最高 余额不超过人民币 58,000 万元的暂时闲置募集资金（其中使用首次公开发行股 票募集资金不超过 8000 万元，使用可转债募集资金不超过 50,000 万元）进行现 金管理。使用期限自董事会审议通过之日起 12 个月内有效，资金在前述额度和 期限范围内，可循环滚动使用。 一、 募集资金基本情况 （一）首次公开发行股票募集资金 公司于 2023 年 7 月 19 日召开 ...

西南证券股份有限公司 关于山东凯盛新材料股份有限公司 募投项目延期的核查意见 西南证券股份有限公司（以下简称"西南证券"或"保荐机构"）作为山东凯盛 新材料股份有限公司（以下简称"凯盛新材"或"公司"）首次公开发行股票并上市 的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《深圳证券交易所创业板股票 上市规则》及《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》等相关法律、法规和规范性文件的规定，对凯盛新材募投项目延 期事项进行了审慎核查，并出具核查意见如下： 一、募集资金投资项目概述 （一）募集资金基本情况 经中国证券监督管理委员会 2021 年 8 月 10 日下发的《关于同意山东凯盛新 材料股份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕2626 号）， 同意公司首次公开发行人民币普通股（A 股）股票 6,000 万股，每股面值 1 元， 每股发行价格为人民币 5.17 元，募集资金总额人民币 31,020.00 万元，扣除与发 行有关的费用（不含增值税）人民币 2,830.85 万元，公司实际 ...